Landscapes / Targets

GPRC5D

17 drugs act on GPRC5D, in 43 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs17

DrugHow it worksCompanyStageNext dateDetails
Monoclonal antibody
Approved 30 Jun 2027Phase 2 trial completes
—
Innovent · Public 1801.HK
Phase 3 31 Dec 2026Phase 2 trial completes
Multi-specific immunoglobulin
Phase 3 14 Jun 2027Phase 2 trial completes
—
Phase 3 Nov 2027Phase 2 trial completes
Gene therapy substances
Bristol Myers Squibb · Public BMY
Phase 3 30 Dec 2027Phase 3 trial completes
—
Phase 1/2 30 Nov 2026soonPhase 1/2 trial completes
—
Phase 1/2 14 Mar 2027Phase 1/2 trial completes
—
Phase 1/2 15 Jun 2027Phase 1/2 trial completes
—
Phase 1/2 Dec 2027Phase 1/2 trial completes
—
AstraZeneca · Public AZN
Phase 1/2 24 Jan 2028Phase 1/2 trial completes
—
Phase 1/2 20 Sep 2029Phase 1/2 trial completes
—
Phase 1 30 Sep 2027Phase 1 trial completes
—
Phase 1 28 Mar 2028Phase 1 trial completes
—
Umoja Biopharma · Private
Phase 1 31 Dec 2029Phase 1 trial completes
—
Phase 1 16 May 2031Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —

About this list

Checked
17 of 17 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow GPRC5D

Following is part of Solo: you see every change to GPRC5D the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in